CERVOMED INC. - COMMON STOCK
8.4900
09-May-25 16:45:00
15 minutes delayed
Stocks
-0.4100
-4.61%
Today's range
8.1000 - 9.1699
ISIN
N/A
Source
NASDAQ
-
CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies
22 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
12 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference
30 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference
17 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
11 Jul 2024 08:51:12 By Nasdaq GlobeNewswire
-
CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes
24 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Appoint William Elder as Chief Financial Officer
20 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
01 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in Upcoming Investor Conferences
28 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 08:30:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in the BIO CEO and Investor Conference
21 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
07 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference 67
05 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
CervoMed to Participate in the Emerging Growth Conference 66
05 Jan 2024 08:00:00 By Nasdaq GlobeNewswire